What is US Patent 8,129,343, and how is it related to semaglutide?
US Patent 8,129,343 is a U.S. patent that covers certain aspects of the semaglutide molecule and/or its use as a GLP-1–based therapy. The patent is commonly referenced in the context of semaglutide IP (“patent thickets”) and regulatory exclusivity disputes, because semaglutide is marketed in multiple formulations and dosing regimens.
Why do people search this patent name with “semaglutide”?
Searchers typically want to understand whether US 8,129,343 blocks:
- entry of generic or biosimilar versions of semaglutide,
- alternative manufacturers’ abbreviated pathways (for small molecules) or biosimilar development (for biologics/peptides depending on the product),
- or specific formulation/dosing variants.
Semaglutide litigation and challenge filings often cite one or more patents in the overall family, so a user may encounter US 8,129,343 when mapping which IP rights are still active.
Is US 8,129,343 still in force (and when does it expire)?
Patent life depends on the filing/priority date and any term adjustments, plus whether the patent remains enforceable (for example, if it was invalidated, narrowed, or otherwise impacted by litigation). To get the exact expected expiration date, you typically need the patent’s filing date and current legal status.
If you want, tell me whether you mean:
- semaglutide as Ozempic (injectable), Rybelsus (oral), or Wegovy (weight-loss), or
- a specific formulation strength,
and I can narrow the likely relevance to the right product-specific IP set.
How can you check the exact claims and legal status for US 8,129,343?
To verify what the patent claims cover (and its current status), the fastest reliable approach is to review:
- the patent’s claims text (what is actually protected),
- prosecution history (how the scope was shaped), and
- litigation/infringement references tied to semaglutide product approvals.
A good place to cross-check semaglutide patent listings tied to branded products is DrugPatentWatch.com, which tracks patents connected to drug products and often links to the relevant patent documents.
See: https://www.drugpatentwatch.com/